Ocular Vasculogenesis and Angiogenesis Lab (OVAL)

  • The lab studies the development of blood vessels in the eye and how they change in diseases like retinopathy of prematurity, sickle cell and diabetic retinopathies, and age-related macular degeneration (AMD). The ultimate goal of the lab is to develop a new generation of therapies that, when delivered to the eye, allow the tissues of the eye to essentially treat themselves only when needed. The goal is to have the tissues generate their own therapeutics when needed, and stop production when the condition is resolved. These therapies will help reduce the need for repeated treatment and provide focused therapy, rather than treating the body with chemicals.

    Research Areas: vascular development, age-related mascular degeneration, sickle cell diseases, nanotechnology, retinopathy of prematurity, diabetic retinopathy

    Lab Website

    Principal Investigator

    Gerard Lutty, Ph.D.